DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication
Artículo científico (JournalArticle)
Biological evaluation as antimalarial of two families of biscationic compounds featuring two different sulphur linkers
Plasmodium falciparum kinases have been widely studied due to their potential as targets for the discovery of alternatives to artemisinin-combined therapies. Their role in parasite blood-stage replication and their homology with human kinases has led to the exploitation of already tested antitumoral kinase inhibitors as antiplasmodial drugs. Plasmodium falciparum choline kinase (PfCK), a cytosolic enzyme involved in phospholipid synthesis, is a promising target for parasite resistant strains. PfCK uses the host choline and catalyzes its transformation in phosphocholine, a key step for the formation of the lipid membranes required by the new parasite progeny inside the erythrocyte. Previously, we described the synthesis of two libraries (PL and FP) of human choline kinase (hCK) inhibitors, which we generated following a green by design approach. Some of these compounds were found to exhibit antitumoral properties. Here, we evaluated the same compounds as potential inhibitors of PfCK and antimalarial agents. Interestingly, while the compounds of the FP library, which feature a disulphide linker, show PfCK inhibition in the nM range independently of the cationic head (FP3 being the most active compound, PfCK IC<inf>50</inf> = 0.16 μM), they show no effect on infected erythrocytes. On the other hand, the compounds of the PL library, which feature a dithioethane linker, show in vitro activity against the parasite but no inhibitory activity against the isolated enzyme (PL40 exhibits the highest antimalarial activity, with IC<inf>50</inf> = 10 nM). This lack of correlation could be due to either cellular disulphide degradation in vitro or to the existence of alternative targets for the dithioethane library. Considering the previously reported anticancer potential of the PL family and the antiparasitic activity reported herein, these compounds may be considered as good starting points for the development of multifunctional drugs., This research was funded by Convocatoria 2019 Proyectos de I + D + i − RTI Tipo B “Ministerio de Innovacion y Ciencia” grant number PID2019-109294RB-I00 funded by MCIN/ AEI/10.13039/501100011033 and “Convocatoria 2020 Proyectos I + D + i del Programa Operativo FEDER 2020”, grant number B-CTS-216- UGR20. E.P. thanks the ERDF project BioDrug (No. 1.1.1.5/19/A/004). The work was also funded by the Instituto de Salud Carlos III Subdirección General de Redes y Centros de Investigación Cooperativa-Red de Investigación Cooperativa en Enfermedades Tropicales (RICET: RD16/0027/0014), grant PID2022-142971OB-I00, funded by MCIN/AEI/ 10.13039/501100011033/FEDER, UE and by the Junta de Andalucía (BIO-199 and CTS-236). The authors thank the Granada University Library for its financial support. The authors thank the Centro de Supercomputación de la Universidad de Granada (CSIRC) for the computing resources., Peer reviewed
Project:
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 PID2019-109294RB-I00
,
MINECO / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 RD16-0027-0014
,
AEI PID2022-142971OB-I00
DOI: http://hdl.handle.net/10261/391451, https://api.elsevier.com/content/abstract/scopus_id/105003073585
HANDLE: http://hdl.handle.net/10261/391451, https://api.elsevier.com/content/abstract/scopus_id/105003073585